Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

NCT00408005 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1895

Enrollment

NIH

Sponsor class

Conditions

T Acute Lymphoblastic Leukemia
T Lymphoblastic Lymphoma

Interventions

DRUG: Asparaginase
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
OTHER: Laboratory Biomarker Analysis
DRUG: Leucovorin Calcium
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Nelarabine
DRUG: Pegaspargase
DRUG: Prednisone
RADIATION: Radiation Therapy
DRUG: Thioguanine
DRUG: Vincristine Sulfate

Sponsor

National Cancer Institute (NCI)